Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Pacific Biosciences of California, Inc.

PACBNASDAQEQUITYCurrent

Changes in Beneficial Ownership

Filed Jun 4, 2026Accepted Jun 4, 2026, 5:27 PM EDTFiling CIK 1299130Accession 0001299130-26-000108
Share

Structured filing — 4

wk-form4_1780608434.xml

Open full document ↗

Filing details

Report period
2026-06-03
Issuer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Issuer CIK
0001299130
Trading symbol
PACB

Reporting owner 1

Name
MOHR MARSHALL
Reporting owner CIK
0001252986
Relationship
Director
Address
PACIFIC BIOSCIENCES OF CALIFORNIA, INC., 1305 O'BRIEN DRIVE, MENLO PARK, CA, 94025

Derivative transactions

Derivative transactions · 1 reported row
SecurityConversion / exercise price (USD)Transaction dateCodeAmountA / DPrice (USD)ExercisableExpiresUnderlying securityUnderlying sharesOwned afterOwnership
Stock Option (right to buy)1.582026-06-03A · Form 4223,492A02026-07-03[F1]2036-06-03Common Stock223,492223,492D
Table key
A · Form 4
Acquisition by grant, award or otherwise under Rule 16b-3(d)
A
Acquired
D
Direct

Footnotes

F1
The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.↩ 1

Signature 1

Signed
/s/ Brett Atkins, Attorney-in-fact
Date
2026-06-04

Company context

Current securities

Recent company filings

  1. SCHEDULE 13G/A - filed by ARK Investment Management LLC regarding PACIFIC BIOSCIENCES OF CALIFORNIA, INC.Aug 14, 2026
  2. S-8 filingAug 7, 2026
  3. 10-Q filingAug 6, 2026
  4. Results of Operations and Financial Condition · Costs Associated with Exit or Disposal Activities · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureAug 5, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJul 9, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.